Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
30. Oktober 2024 09:30 ET
|
KUEHN LAW, PLLC
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
18. Oktober 2024 09:17 ET
|
KUEHN LAW, PLLC
Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
Revance Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
03. November 2021 11:21 ET
|
Portnoy Law
LOS ANGELES, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) investors that the firm has initiated an...